Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1989 1
1991 1
1994 1
1995 3
1996 2
1997 5
1998 1
1999 2
2000 2
2001 1
2002 3
2003 1
2004 3
2005 3
2006 2
2007 2
2008 6
2009 1
2010 1
2012 1
2013 1
2014 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. Chao EC, et al. Hum Mutat. 2008 Jun;29(6):852-60. doi: 10.1002/humu.20735. Hum Mutat. 2008. PMID: 18383312 Free article.
MAPP-MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predictive value [PPV] 98%; negative predictive value [NPV], 89%), such as SIFT and PolyPhen. ...
MAPP-MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predic
The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.
Matsuoka T, Yashiro M. Matsuoka T, et al. Biomolecules. 2023 Oct 19;13(10):1551. doi: 10.3390/biom13101551. Biomolecules. 2023. PMID: 37892233 Free PMC article. Review.
Therefore, elucidating the role of TGF-beta signaling in carcinogenesis, cancer invasion, and metastasis will provide novel basic insight for diagnosis and prognosis and the development of new molecularly targeted therapies for gastrointestinal cancers. ...
Therefore, elucidating the role of TGF-beta signaling in carcinogenesis, cancer invasion, and metastasis will provide novel basic insight fo …
Management of endometrial precancers.
Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL; Society of Gynecologic Oncology Clinical Practice Committee. Trimble CL, et al. Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: 10.1097/aog.0b013e31826bb121. Obstet Gynecol. 2012. PMID: 23090535 Free PMC article. Review.
We reviewed studies pertaining to the diagnostic challenges of endometrial precancers, their predictive value, and evidence to support management strategies. Currently, two diagnostic schemas are in use: the four-class 1994 World Health Organization hyperplasia system, bas …
We reviewed studies pertaining to the diagnostic challenges of endometrial precancers, their predictive value, and evidence to suppor …
Hereditary ovarian carcinoma.
Gallion HH, Smith SA. Gallion HH, et al. Semin Surg Oncol. 1994 Jul-Aug;10(4):249-54. doi: 10.1002/ssu.2980100404. Semin Surg Oncol. 1994. PMID: 8091066 Review.
The molecular basis of ovarian cancer.
Gallion HH, Pieretti M, DePriest PD, van Nagell JR Jr. Gallion HH, et al. Cancer. 1995 Nov 15;76(10 Suppl):1992-7. doi: 10.1002/1097-0142(19951115)76:10+<1992::aid-cncr2820761315>3.0.co;2-u. Cancer. 1995. PMID: 8634990 Review.
RESULTS: Overexpression of the HER-2/neu oncogene is present in approximately one third of ovarian cancers and is associated with poor prognosis. Mutations of the K-ras oncogene have been identified in a similar proportion of mucinous ovarian tumors, including borderline t …
RESULTS: Overexpression of the HER-2/neu oncogene is present in approximately one third of ovarian cancers and is associated with poor pr
Molecular and genetic advances in gastrointestinal cancer: state of the art.
Younes Z, Johnson DA. Younes Z, et al. Dig Dis. 1997 Jul-Oct;15(4-5):275-301. doi: 10.1159/000171604. Dig Dis. 1997. PMID: 9359017 Review.
This new information will be of tremendous help in the early detection, the prognostication, and hopefully the therapy of premalignant and malignant gastrointestinal diseases. ...
This new information will be of tremendous help in the early detection, the prognostication, and hopefully the therapy of premalignan …
Aspirin in gastrointestinal oncology: new data on an old friend.
Langley RE, Rothwell PM. Langley RE, et al. Curr Opin Oncol. 2014 Jul;26(4):441-7. doi: 10.1097/CCO.0000000000000098. Curr Opin Oncol. 2014. PMID: 24840525 Review.
In Lynch syndrome (hereditary nonpolyposis colon cancer), aspirin reduces cancer incidence and should be considered standard care. Mutations in the PIK3CA gene may be a potential predictive marker of response to aspirin after a cancer diagnosis, though pharmacological cons …
In Lynch syndrome (hereditary nonpolyposis colon cancer), aspirin reduces cancer incidence and should be considered standard care. Mutations …
45 results